CA2437762C - Emulsions en formes posologiques solides pour l'administration orale - Google Patents

Emulsions en formes posologiques solides pour l'administration orale Download PDF

Info

Publication number
CA2437762C
CA2437762C CA2437762A CA2437762A CA2437762C CA 2437762 C CA2437762 C CA 2437762C CA 2437762 A CA2437762 A CA 2437762A CA 2437762 A CA2437762 A CA 2437762A CA 2437762 C CA2437762 C CA 2437762C
Authority
CA
Canada
Prior art keywords
drug
emulsion
dosage form
solid dosage
powder
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA2437762A
Other languages
English (en)
Other versions
CA2437762A1 (fr
Inventor
S. Indiran Pather
Sangeeta V. Gupte
Rajendra K. Khankari
Jon Hontz
Ramya Kumbale
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cima Labs Inc
Original Assignee
Cima Labs Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cima Labs Inc filed Critical Cima Labs Inc
Publication of CA2437762A1 publication Critical patent/CA2437762A1/fr
Application granted granted Critical
Publication of CA2437762C publication Critical patent/CA2437762C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A61K9/025—Suppositories; Bougies; Bases therefor; Ovules characterised by shape or structure, e.g. hollow layered, coated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)

Abstract

La présente invention concerne de nouvelles compositions d'émulsion qui améliorent le taux et/ou l'ampleur d'absorption de médicaments. Les nouvelles compositions d'émulsion de la présente invention comprennent des émulsions renfermant des médicaments adsorbés sur des particules solides qui peuvent être davantage formulés sous formes posologiques solides, des procédés de préparation de telles compositions d'émulsion et leurs utilisations. Les compositions d'émulsion et leurs formes posologiques améliorent la charge de médicaments et la biodisponibilité d'une large gamme de médicaments connus pour ou susceptibles de présenter une faible biodisponibilité par l'utilisation de plusieurs mécanismes différents.
CA2437762A 2001-02-23 2001-02-23 Emulsions en formes posologiques solides pour l'administration orale Expired - Fee Related CA2437762C (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2001/005978 WO2002083102A1 (fr) 2001-02-23 2001-02-23 Emulsions en formes posologiques solides pour l'administration orale

Publications (2)

Publication Number Publication Date
CA2437762A1 CA2437762A1 (fr) 2002-10-24
CA2437762C true CA2437762C (fr) 2010-08-10

Family

ID=21742362

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2437762A Expired - Fee Related CA2437762C (fr) 2001-02-23 2001-02-23 Emulsions en formes posologiques solides pour l'administration orale

Country Status (5)

Country Link
EP (1) EP1361866A4 (fr)
JP (1) JP5684440B2 (fr)
AU (1) AU2001241730B2 (fr)
CA (1) CA2437762C (fr)
WO (1) WO2002083102A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7815937B2 (en) 1998-10-27 2010-10-19 Biovail Laboratories International Srl Quick dissolve compositions and tablets based thereon
FR2851918B1 (fr) * 2003-03-06 2006-06-16 Poudre impregnee ameliorant la biodisponibilite et/ou la solubilite et procede de fabrication
WO2010030667A2 (fr) * 2008-09-09 2010-03-18 Cima Labs Inc. Forme galénique pour composés faiblement ionisables
US20120213855A1 (en) * 2011-02-17 2012-08-23 Cima Labs Inc. Dosage forms for weakly ionizable compounds
ES2395801B1 (es) * 2011-06-23 2014-06-06 María Carmen PARDINA PALLEJÀ "pentoxifilina por vía transvaginal para el tratamiento de la infertilidad"

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH586568A5 (fr) * 1972-04-10 1977-04-15 Hoffmann La Roche
GB1468815A (en) * 1973-10-18 1977-03-30 Vymatt Sa Pharmaceutical compositions
JPS58213073A (ja) * 1982-06-07 1983-12-10 Masatoshi Yamada 油状物質の固形化法
FR2561916B1 (fr) * 1984-03-30 1987-12-11 Lafon Labor Forme galenique pour administration orale et son procede de preparation par lyophilisation d'une emission huile dans eau
US5800834A (en) * 1996-06-10 1998-09-01 Spireas; Spiridon Liquisolid systems and methods of preparing same
JP4027535B2 (ja) * 1998-05-26 2007-12-26 エーザイ・アール・アンド・ディー・マネジメント株式会社 脂溶性薬物を含有した粉末
JP2000016934A (ja) * 1998-06-30 2000-01-18 Eisai Co Ltd テプレノンを含有した錠剤
EP2127642A3 (fr) * 1998-08-13 2010-02-24 Cima Labs, Inc. Microémulsions en tant que formes galéniques solides pour administration orale
US5997905A (en) * 1998-09-04 1999-12-07 Mcneil-Ppc Preparation of pharmaceutically active particles

Also Published As

Publication number Publication date
WO2002083102A1 (fr) 2002-10-24
JP5684440B2 (ja) 2015-03-11
CA2437762A1 (fr) 2002-10-24
EP1361866A1 (fr) 2003-11-19
AU2001241730B2 (en) 2007-03-15
JP2004524370A (ja) 2004-08-12
EP1361866A4 (fr) 2007-10-17

Similar Documents

Publication Publication Date Title
US6692771B2 (en) Emulsions as solid dosage forms for oral administration
US6280770B1 (en) Microemulsions as solid dosage forms for oral administration
US6190692B1 (en) Time-specific controlled release capsule formulations and method of preparing same
AU744580B2 (en) Spheroids, preparation method and pharmaceutical compositions
CN113329736B (zh) 萜烯类药物组合物自乳化口服制剂及制备方法、应用
JP2002522473A5 (fr)
JPH10511959A (ja) フェノフィブレートおよびポリグリコール化グリセリドを含有する薬学的組成物
WO2002011701A1 (fr) Composition pharmaceutique a liberation controlee
EP0152292A2 (fr) Gélules contenant de l'acétaminophène
CA2735660C (fr) Forme galenique pour composes faiblement ionisables
WO2021016134A1 (fr) Préparation d'ingrédients actifs lipophiles
CN1475208A (zh) 舍曲林的缓释剂型
US20120213855A1 (en) Dosage forms for weakly ionizable compounds
US20150342882A1 (en) Methods of treatment using cadotril compositions
CA2437762C (fr) Emulsions en formes posologiques solides pour l'administration orale
AU2001241730A1 (en) Emulsions as solid dosage forms for oral administration
US20040033257A1 (en) Pharmaceutical formulation in a drug delivery system and process for preparing the same
JP2005508369A (ja) マイクロカプセルマトリックス微小球、吸収を促進する薬剤組成物および方法
JP4840793B2 (ja) 撥水性成分を配合することを特徴とする難水溶性薬物の腸溶顆粒製剤
JPH0115A (ja) 吸収改善製剤

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20200224